关键信息
-
基因名
CHRDL2
- 应用
-
别名
BNF1; CHL2; Breast Tumor Novel Factor 1; Chordin-related protein 2
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8VEA6
-
表达区间
Ser27~Ser169
-
分子量
18&20kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
CHRDL2, or Chordin-like protein 2, is a member of the Chordin family of proteins, which play critical roles in embryonic development and the regulation of bone morphogenetic proteins (BMPs). This protein is primarily expressed in the central nervous system and has been implicated in various developmental processes, including neural differentiation and tissue patterning. Research has shown that CHRDL2 may act as a BMP antagonist, modulating signaling pathways that are crucial for organogenesis and maintaining tissue homeostasis. Given its involvement in these fundamental biological processes, CHRDL2 has garnered attention as a potential therapeutic target in regenerative medicine and neurodevelopmental disorders. The study of recombinant CHRDL2 proteins allows researchers to investigate its functional properties in detail, elucidate its mechanisms of action, and explore its role in disease pathogenesis. Advances in recombinant technology have facilitated the production and purification of CHRDL2, enabling systematic analyses of its interactions with other signaling molecules and effects on cellular behavior. Ongoing studies aim to uncover the precise biological functions of CHRDL2 and its potential applicability in developing novel treatment strategies for disorders where BMP signaling is disrupted, such as certain cancers or degenerative diseases. Through this research, a deeper understanding of CHRDL2's role in development and disease may emerge, paving the way for innovative therapeutic interventions.
